In order to access this content you must be logged in and have a subscription to PL Intelligence.
PL Intelligence is a one-stop environment for time-conscious executives. Keeping you abreast of the latest developments in the life sciences industry, saving you time and money when you need it most.
Immune Response licenses Hybridon's 2nd-generation CpG DNA adjuvant
The Immune Response Corporation announces payment from Agouron Pharmaceuticals
Immune Response receives two U.S. patents
Immune Response to pursue development of preventive HIV vaccine
Immune Response announces restructuring of license agreement
Immune Response acquires T cell receptor technology
Immune Response Corporation granted patent
Aethlon Medical Announces HIV-AIDS Research Collaboration
Immune Response reaches agreement with Maryland Biotech Institute
© Copyright 1995-2009 Pharmalicensing, a division of UTEK Europe Ltd 
All rights reserved. Terms and Conditions | Contact us
